This article explores how senotherapeutics target senescent cells in the brain to reduce neuroinflammation and improve cognition, based on recent preclinical studies and emerging clinical trials. Emer...
Recent research shows compounds like P7C3-A20 restore NAD+ levels, reversing Alzheimer’s pathology in mice, with early clinical trials indicating safety and potential efficacy in humans. Breakth...
Advances in mitochondrial uncouplers like BAM15 offer safer options for weight management and anti-aging, supported by 2023 research and ongoing clinical trials targeting metabolic efficiency. Cutting...
In 2025, aging research sees major advancements with senolytics and mitochondrial therapies, backed by clinical trials and shifting medical attitudes towards treating aging as a condition. Recent tria...
The FDA-approved digital therapeutics market is rapidly expanding, offering effective tools for conditions like diabetes and ADHD, supported by clinical data and growing insurance coverage. Digital th...
Analytical review of personalized nutrition’s growth, using genetic testing and AI, with insights from recent studies at Stanford and King’s College London, focusing on ethical and regulat...
FDA-approved digital therapeutics are revolutionizing healthcare by integrating evidence-based apps for conditions like diabetes and mental health, enhancing treatment through real-time data and behav...
Explore how AI and genetic testing are revolutionizing nutrition by tailoring diets to individual metabolic and genetic data, improving health outcomes while raising ethical questions about data priva...
A 2023 study in ‘Aging Cell’ shows GDF3 drives inflammatory macrophage polarization in aging mice, linking it to metabolic decline and offering new therapeutic avenues for age-related dise...
Axolotls, with their unique regeneration and negligible senescence, offer groundbreaking insights for anti-aging therapies, driven by recent epigenetic studies and biotech innovations. Recent studies ...
